In this ASX Briefs podcast, Optiscan CEO Dr. Camile Farah discusses the future of precision surgery, and the impact InVue could have in cancer treatment.

During the interview, Camile speaks about Optiscan's strategic focus and its know-how agreement with the Mayo Clinic in advancing robotic surgery technology.

"Camile's insights reveal how high-resolution, sub-micron level imaging is setting new standards in medical technology, empowering surgeons to make more informed decisions on the spot."